MetaVia Inc.
MTVA - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.82M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $6.82 Million |
|---|---|
| Enterprise Value | $-5,635,344.00 |
| Earnings per Share | $-7.35 |
| Beta | 0.96 |
| Outstanding Shares | 5,931,875 |
Return
| Return on Equity | -211.76% |
|---|---|
| Return on Assets | -108.85% |
| Return on Invested Capital | -217.03% |
Valuation & Multiples
| P/E Ratio | -0.35 |
|---|---|
| PEG | -1.05 |
| Price to Sales | - |
| Price to Book Ratio | 1.15 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.52 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$-0.82
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.73
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.17%▼ 4.71% |
|---|---|
| Total Invested | $15,700▼ 96.21% |
| Investors Holding | 1▼ 16.00% |
About NeuroBo Pharmaceuticals Inc
8 employees
CEO: Hyung Heon Kim
Headquartered in Cambridge, Massachusetts, MetaVia Inc. operates as a clinical-stage biotechnology company with a core focus on discovering and commercializing novel pharmaceutical solutions for cardiometabolic disorders. Its leading inv...